Fengling Li Selected Research

Fengling Li Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 01/2012
8	Inflammation (Inflammations) 10/2019 - 07/2002
7	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2015
6	Colitis 01/2012 - 12/2007
4	Carcinogenesis 10/2021 - 08/2014
4	Leukemia 10/2019 - 04/2013
3	COVID-19 10/2021 - 01/2021
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2012 - 12/2007
2	Multiple Myeloma 01/2022 - 11/2021
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 10/2017
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 04/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2019
2	Seizures (Absence Seizure) 09/2019 - 01/2016
2	Enterocolitis 12/2002 - 07/2002
1	Circulating Neoplastic Cells 04/2022
1	Liver Neoplasms (Liver Cancer) 04/2022
1	Pathologic Complete Response 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021
1	Friedreich Ataxia (Friedreich's Ataxia) 12/2020
1	Endometriosis 10/2020
1	Cysts 10/2020
1	Adenocarcinoma 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2019
1	Epilepsy (Aura) 09/2019
1	Cognitive Dysfunction 09/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Lymphatic Metastasis 04/2017
1	Gallbladder Neoplasms (Gallbladder Cancer) 04/2017

Drug/Important Bio-Agent (IBA)

8	Histones (Histone)IBA 01/2019 - 01/2013
6	EnzymesIBA 04/2022 - 01/2013
6	MethyltransferasesIBA 11/2021 - 01/2013
6	Lysine (L-Lysine)FDA Link 11/2021 - 01/2013
5	Biological ProductsIBA 01/2021 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2002
4	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2021 - 04/2018
3	Protein Isoforms (Isoforms)IBA 01/2022 - 08/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2002
3	Transcription Factors (Transcription Factor)IBA 10/2021 - 12/2007
3	Histone MethyltransferasesIBA 12/2020 - 01/2015
3	coactivator-associated arginine methyltransferase 1IBA 10/2020 - 04/2018
3	CytokinesIBA 01/2012 - 09/2009
3	Polysaccharides (Glycans)IBA 10/2003 - 07/2002
3	Peptidoglycan (Murein)IBA 10/2003 - 07/2002
2	Long Noncoding RNAIBA 01/2022 - 04/2017
2	human ERBB2 proteinIBA 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 10/2021 - 02/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2012
2	abivertinibIBA 01/2020 - 10/2019
2	Small Interfering RNA (siRNA)IBA 10/2019 - 01/2015
2	Kainic Acid (Kainate)IBA 09/2019 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2012 - 05/2011
2	Peptides (Polypeptides)IBA 01/2012 - 12/2007
2	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 10/2003 - 07/2002
2	PolymersIBA 12/2002 - 07/2002
2	Kininogens (Kininogen)IBA 12/2002 - 07/2002
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2022
1	human MIRN424 micrornaIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	human MIRN143 microRNAIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	human MIRN211 microRNAIBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 11/2021
1	Dexmedetomidine FDA Link 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	Bromodeoxyuridine (BrdU)IBA 10/2021
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 10/2021
1	rhophilinIBA 10/2021
1	RNA IIBA 10/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	FrataxinIBA 12/2020
1	PeroxiredoxinsIBA 10/2020
1	ApigeninIBA 01/2020
1	PhytochemicalsIBA 01/2020
1	Polycomb-Group ProteinsIBA 01/2020
1	FlavonoidsIBA 01/2020
1	HomoharringtonineIBA 10/2019
1	ibrutinibIBA 10/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2019
1	methyl-lysineIBA 01/2019
1	BI-9321IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	human NSD3 proteinIBA 01/2019
1	Untranslated RNA (Noncoding RNA)IBA 10/2017
1	Cadherins (E-Cadherin)IBA 10/2017
1	ginsenoside Rg1IBA 06/2016

Therapy/Procedure

8	Therapeutics 10/2021 - 01/2012
2	Neoadjuvant Therapy 01/2022 - 01/2021
1	Intraperitoneal Injections 09/2019